相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential ability of formononetin to stimulate proliferation of endothelial cells and breast cancer cells via a feedback loop involving MicroRNA-375, RASD1, and ERα
Jian Chen et al.
MOLECULAR CARCINOGENESIS (2018)
mTOR Inhibitor Therapy and Metabolic Consequences: Where Do We Stand?
Aleksandra Kezic et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Aurantoside C Targets and Induces Apoptosis in Triple Negative Breast Cancer Cells
Sumi Shrestha et al.
MARINE DRUGS (2018)
Adrenoceptors promote glucose uptake into adipocytes and muscle by an insulin-independent signaling pathway involving mechanistic target of rapamycin complex 2
Saori Mukaida et al.
PHARMACOLOGICAL RESEARCH (2017)
MFN2 suppresses cancer progression through inhibition of mTORC2/Akt signaling
Ke Xu et al.
SCIENTIFIC REPORTS (2017)
mTOR Signaling in Growth, Metabolism, and Disease
Robert A. Saxton et al.
CELL (2017)
An overview of triple-negative breast cancer
Pankaj Kumar et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Global Cancer Incidence and Mortality Rates and Trends-An Update
Lindsey A. Torre et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Trends in Second-Hand Tobacco Smoke Exposure Levels at Home among Viet Nam School Children Aged 13-15 and Associated Factors
Tuan Lam Nguyen et al.
Asian Pacific Journal of Cancer Prevention (2016)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Phosphoinositides: Key modulators of energy metabolism
Dave Bridges et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2015)
Formononetin Induces Apoptosis of Human Osteosarcoma Cell Line U2OS by Regulating the Expression of Bcl-2, Bax and MiR-375 In Vitro and In Vivo
Wei Hu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
Formononetin promotes angiogenesis through the estrogen receptor alpha-enhanced ROCK pathway
Shang Li et al.
SCIENTIFIC REPORTS (2015)
Formononetin Inhibits Migration and Invasion of MDA-MB-231 and 4T1 Breast Cancer Cells by Suppressing MMP-2 and MMP-9 Through PI3K/AKT Signaling Pathways
R. Zhou et al.
HORMONE AND METABOLIC RESEARCH (2014)
Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer
Georgios Lazaridis et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2014)
A Diverse Array of Cancer-Associated MTOR Mutations Are Hyperactivating and Can Predict Rapamycin Sensitivity
Brian C. Grabiner et al.
CANCER DISCOVERY (2014)
Estrogen Receptor Beta-Mediated Proliferative Inhibition and Apoptosis in Human Breast Cancer by Calycosin and Formononetin
Jian Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2013)
Isolation of Anti-Inflammatory Fractions and Compounds from the Root of Astragalus membranaceus
Patrick Kwok-Kin Lai et al.
PHYTOTHERAPY RESEARCH (2013)
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer
Guy Jerusalem et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effects
Qian-Mei Zhou et al.
EUROPEAN JOURNAL OF CANCER (2011)
Reversal of multidrug resistance in human breast cancer cells by Curcuma wenyujin and Chrysanthemum indicum
L. Yang et al.
PHYTOMEDICINE (2011)
AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
Marin Marinov et al.
CLINICAL CANCER RESEARCH (2009)
分享论文
